Psychiatr. praxi. 2020;21(3):149-153 | DOI: 10.36290/psy.2020.026

Recovery in borderline personality disorder

MUDr. Vlastimil Nesnídal1,2,3, prof. MUDr. Jan Praško, CSc.1, Mgr. Marie Ocisková, Ph.D.1, MUDr. Kamila Minaříková4, PhDr. Michaela Holubová, Ph.D.1, MUDr. Jakub Vaněk1, MUDr. Lucie Bundárová1, MUDr. Kryštof Kantor1, Mgr. František Hodný2, PhDr. Miloš Šlepecký, Ph.D.
1 Univerzita Palackého v Olomouci, Lékařská fakulta a Fakultní nemocnice Olomouc, Klinika psychiatrie, Olomouc
2 Univerzita Konštantína Filozofa v Nitre, Fakulta sociálnych vied a zdravotnictva, Katedra psychologických vied, Slovensko
3 Katedra psychoterapie, IPVZ Praha
4 Krajská nemocnice Liberec, Centrum psychiatrie, Liberec

Historically, borderline personality disorder (BPD) has been viewed as alifelong and highly disabling disorder. However, investigations throughout the past two decades have confronted these postulations. BPD is most commonly diagnosed during early adulthood, and the course of the disorder is generally similar, with decreasing symptomatology over time. The review aims to deliver up-to-date information on the concept of recovery in BPD patients, and possibilities to reach it. Acomputerized database search was conducted in PubMed and Web of Science, using various combinations of keywords relevant to the topic. The search was filtered for the time period between January 1990 and December 2019 The results were reviewed and discussed in four distinct categories relevant to the aim of this study: 1) Why it is meaningful to consider the concept of recovery in BPD, 2) Recovery connected to alleviation of symptoms during the course of time, 3) Effective treatment of the BPD and recovery, 4) Patient'staking responsibility for the recovery. After reviewing the current literature, we could propose aconclusion, that the recovery, including not only reduction of symptoms, but also building apositive personal identity and purpose of life, could be viewed as areachable treatment objective. However, the necessary requirement is patient'sown involvement in taking responsibility for the therapy.

Results: Complete remission or complete disappearance of the symptoms of borderline personality disorder usually does not occur soon after the start of treatment, so we consider complete recovery as adistant goal. Patients with BPD do not have apoor prognosis if they seek treatment and are actively involved. Patients with BPD are open to treatment and can be treated well, but the condition is that they follow their treatment program and monitor their progress and learn how to cope effectively with their problems.

Conclusion: Recovery is an achievable goal in the treatment of individuals with BPD. Stable recovery is an option that requires long-term maintenance of adaptive patterns created in treatment and awillingness to seek help in the event of acrisis. Aprerequisite for recovery is the patient taking responsibility for his or her health condition. Psychotherapy and psychosocial rehabilitation and, in addition, pharmacotherapy help people with borderline personality disorder increase their quality of life and can significantly help on their personal path to recovery.

Keywords: borderline personality disorder, remission, recovery, course, management, pharmacotherapy, psychotherapy, schematherapy, dialectical behavior therapy, transference focus therapy, mentalization based therapy.

Published: December 10, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nesnídal V, Praško J, Ocisková M, Minaříková K, Holubová M, Vaněk J, et al.. Recovery in borderline personality disorder. Psychiatr. praxi. 2020;21(3):149-153. doi: 10.36290/psy.2020.026.
Download citation

References

  1. Gunderson JG. Borderline personality disorder. SUNY Press; 1984.
  2. Frances A, Fyer M, Clarkin J. Personality and suicide. Annals of the New York Academy of Sciences 1986; 487(1): 281-295. Go to original source... Go to PubMed...
  3. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G, Weinberg I, Gunderson JG. The 10-year course of physically self-destructive acts reported by borderline patients and axis II comparison subjects. Acta Psychiatrica Scandinavica 2008; 117(3): 177-184. Go to original source... Go to PubMed...
  4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub; 2013. Go to original source...
  5. Higgitt A, Fonagy P. Psychotherapy in borderline and narcissistic personality disorder. The British Journal of Psychiatry 1992; 161(1): 23-43. Go to original source... Go to PubMed...
  6. Markham D, Trower P. The effects of the psychiatric label 'borderline personality disorder'on nursing staff's perceptions and causal attributions for challenging behaviours. British Journal of Clinical Psychology 2003; 42(3): 243-256. Go to original source... Go to PubMed...
  7. NIMHE. Personality disorder: no longer a diagnosis of exclusion. United Kingdom: Department of Health, National Institute for Mental Health in England 2003.
  8. Skegg K. Self‑harm. The Lancet 2005; 366(9495): 1471-1483. Go to original source... Go to PubMed...
  9. Comtois KA, Carmel A. Borderline personality disorder and high utilization of inpatient psychiatric hospitalization: concordance between research and clinical diagnosis. The journal of behavioral health services & research 2016; 43(2): 272-280. Go to original source... Go to PubMed...
  10. Slotema CW, Niemantsverdriet MB, Blom JD, van der Gaag M, Hoek HW, Sommer IE. Suicidality and hospitalisation in patients with borderline personality disorder who experience auditory verbal hallucinations. European psychiatry 2017; 41: 47-52. Go to original source... Go to PubMed...
  11. Lewis KL, Fanaian M, Kotze B, Grenyer BF. Mental health presentations to acute psychiatric services: 3-year study of prevalence and readmission risk for personality disorders compared with psychotic, affective, substance or other disorders. BJ Psych 2019; 5(1). Go to original source... Go to PubMed...
  12. Zanarini MC, Laudate CS, Frankenburg FR, Wedig MM, Fitzmaurice G. Reasons for self‑mutilation reported by borderline patients over 16 years of prospective follow‑up. Journal of personality disorders 2013; 27(6): 783-794. Go to original source... Go to PubMed...
  13. Sansone RA, Sellbom M, Songer DA. Borderline personality disorder and mental health care utilization: The role of self‑harm. Personality Disorders: Theory, Research, and Treatment 2018; 9(2): 188. Go to original source... Go to PubMed...
  14. Kienast T, Stoffers J, Bermpohl F, Lieb K. Borderline personality disorder and comorbid addiction: epidemiology and treatment. Deutsches Ärzteblatt International 2014; 111(16):280. Go to original source... Go to PubMed...
  15. Heath LM, Laporte L, Paris J, Hamdullahpur K, Gill KJ. Substance misuse is associated with increased psychiatric severity among treatment‑seeking individuals with borderline personality disorder. Journal of personality disorders 2018; 32(5): 694-708. Go to original source... Go to PubMed...
  16. Parmar A, Kaloiya G. Comorbidity of personality disorder among substance use disorder patients: A narrative review. Indian journal of psychological medicine 2018; 40(6): 517. Go to original source... Go to PubMed...
  17. Joyce PR, Light KJ, Rowe SL, Cloninger CR, Kennedy MA. Self‑mutilation and suicide attempts: relationships to bipolar disorder, borderline personality disorder, temperament and character. Australian and New Zealand Journal of Psychiatry 2010; 44(3): 250-257. Go to original source... Go to PubMed...
  18. Goodman M, Tomas IA, Temes CM, Fitzmaurice GM, Aguirre BA, Zanarini MC. Suicide attempts and self-injurious behaviours in adolescent and adult patients with borderline personality disorder. Personality and mental health 2017; 11(3): 157-163. Go to original source... Go to PubMed...
  19. DeShong HL, Tucker RP. Borderline personality disorder traits and suicide risk: The mediating role of insomnia and nightmares. Journal of affective disorders 2019; 244: 85-91. Go to original source... Go to PubMed...
  20. Cailhol L, Pelletier É, Rochette L, Laporte L, David P, Villeneuve É, Paris J, Lesage A. Prevalence, mortality, and health care use among patients with cluster B personality disorders clinically diagnosed in Quebec: a provincial cohort study, 2001-2012. The Canadian Journal of Psychiatry 2017; 62(5): 336-342. Go to original source... Go to PubMed...
  21. Kjær JN, Biskin R, Vestergaard C, Munk‑J rgensen P. All‑cause mortality of hospital‑treated borderline personality disorder: a nationwide cohort study. Journal of personality disorders 2018: 1-3.
  22. Kuo CJ, Chen WY, Tsai SY, Chen PH, Ko KT, Chen CC. Excessive mortality and causes of death among patients with personality disorder with comorbid psychiatric disorders. Social psychiatry and psychiatric epidemiology 2019; 54(1): 121-130. Go to original source... Go to PubMed...
  23. Jacob KS. Recovery model of mental illness: A complementary approach to psychiatric care. Indian journal of psychological medicine 2015; 37(2): 117. Go to original source... Go to PubMed...
  24. Roberts G, Wolfson P. The rediscovery of recovery: open to all. Advances in psychiatric treatment 2004; 10(1): 37-48. Go to original source...
  25. Ralph RO, Lambert D, Kidder KA. The recovery perspective and evidence‑based practice for people with serious mental illness. Behav Heal Recover Manag Proj 2002.
  26. Copeland ME. Wellness recovery action planning 1997.
  27. Deegan P. Recovery as a journey of the heart. Psychiatric rehabilitation journal 1996; 19(3): 91. Go to original source...
  28. Tew J, Ramon S, Slade M, Bird V, Melton J, Le Boutillier C. Social factors and recovery from mental health difficulties: a review of the evidence. The British Journal of Social Work 2012; 42(3): 443-460. Go to original source...
  29. Slade M, Amering M, Oades L. Recovery: an international perspective. Epidemiology and Psychiatric Sciences 2008; 17(2): 128-137. Go to original source... Go to PubMed...
  30. Liberman RP, Kopelowicz A, Ventura J, Gutkind D. Operational criteria and factors related to recovery from schizophrenia. International Review of Psychiatry 2002; 14(4): 256-272. Go to original source...
  31. Whitehorn D, Brown J, Richard J, Rui Q, Kopala L. Multiple dimensions of recovery in early psychosis. International Review of Psychiatry 2002; 14(4): 273-283. Go to original source...
  32. Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. American Journal of Psychiatry 2004; 161(3): 473-479. Go to original source... Go to PubMed...
  33. Harrow M, Grossman LS, Jobe TH, Herbener ES. Do patients with schizophrenia ever show periods of recovery? A 15-year multi‑follow‑up study. Schizophrenia Bulletin 2005; 31(3): 723-734. Go to original source... Go to PubMed...
  34. Kopelowicz A, Liberman RP, Ventura J, Zarate R, Mintz J. Neurocognitive correlates of recovery from schizophrenia. Psychological Medicine 2005; 35(8): 1165-1173. Go to original source... Go to PubMed...
  35. Dahl AA. Controversies in diagnosis, classification and treatment of borderline personality disorder. Current Opinion in Psychiatry 2008; 21(1): 78-83. Go to original source... Go to PubMed...
  36. Bendelow G. Ethical aspects of personality disorders. Current Opinion in Psychiatry 2010; 23(6): 546-549. Go to original source... Go to PubMed...
  37. World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. World Health Organization; 1993.
  38. National Collaborating Centre for Mental Health. Borderline personality disorder: recognition and management. London: Department of Health. 2009.
  39. National Institute for Mental Health in England. Breaking the cycle of rejection: The personality disorder capabilities framework. Policy implementation guidance for the development of services for people with personality disorder. 2003.
  40. Castillo H. Personality Disorder: Temperament Or Trauma?: an Account of an Emancipatory Research Study Carried Out by Service Users Diagnosed with Personality Disorder. Jessica Kingsley Publishers; 2003.
  41. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow‑up study. American Journal of Psychiatry 2012; 169(5): 476-483. Go to original source... Go to PubMed...
  42. Adshead G. Murmurs of discontent: treatment and treatability of personality disorder. Advances in Psychiatric Treatment 2001; 7(6): 407-415. Go to original source...
  43. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Time to attainment of recovery from borderline personality disorder and stability of recovery: A 10-year prospective follow‑up study. American Journal of Psychiatry 2010; 167(6): 663-667. Go to original source... Go to PubMed...
  44. Westen D, Ludolph P, Misle B, Ruffins S, Block J. Physical and sexual abuse in adolescent girls with borderline personality disorder. American journal of orthopsychiatry 1990; 60(1): 55-66. Go to original source... Go to PubMed...
  45. Ryan RM. The developmental line of autonomy in the etiology, dynamics, and treatment of borderline personality disorders. Development and Psychopathology 2005; 17(4): 987-1006. Go to original source... Go to PubMed...
  46. Vriend‑Bosma SA. The course of borderline personality disorder within adults. A literature review. Tijdschrift voor psychiatrie 2011; 53(1): 27-36. Go to PubMed...
  47. Davidson KM, Tyrer P, Norrie J, Palmer SJ, Tyrer H. Cognitive therapy v. usual treatment for borderline personality disorder: prospective 6-year follow‑up. The British Journal of Psychiatry 2010; 197(6): 456-462. Go to original source... Go to PubMed...
  48. Zanarini MC, Frankenburg FR, Hennen J, Silk KR. The longitudinal course of borderline psychopathology: 6-year prospective follow‑up of the phenomenology of borderline personality disorder. American Journal of Psychiatry 2003; 160(2): 274-283. Go to original source... Go to PubMed...
  49. Zanarini MC, Frankenburg FR, Reich DB, Conkey LC, Fitzmaurice GM. Treatment rates for patients with borderline personality disorder and other personality disorders: a 16-year study. Psychiatric Services 2015; 66(1): 15-20. Go to original source... Go to PubMed...
  50. Skodol AE, Gunderson JG, Shea MT, McGlashan TH, Morey LC, Sanislow CA, Bender DS, Grilo CM, Zanarini MC, Yen S, Pagano ME. The collaborative longitudinal personality disorders study (CLPS): Overview and implications. Journal of personality disorders 2005;19(5): 487-504. Go to original source... Go to PubMed...
  51. Katsakou C, Marougka S, Barnicot K, Savill M, White H, Lockwood K, Priebe S. Recovery in borderline personality disorder (HPO): a qualitative study of service users' perspectives. PloS one 2012; 7(5). Go to original source...
  52. Gillard S, Turner K, Neffgen M. Understanding recovery in the context of lived experience of personality disorders: a collaborative, qualitative research study. BMC psychiatry 2015; 15(1): 183. Go to original source... Go to PubMed...
  53. Doering S, Hörz S, Rentrop M, Fischer‑Kern M, Schuster P, Benecke C, Buchheim A, Martius P, Buchheim P. Transference‑focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial. The British Journal of Psychiatry 2010; 196(5): 389-395. Go to original source... Go to PubMed...
  54. Paris J. The Outcome of Borderline Personality Disorder: Good for Most But Not All Patients. The American journal of psychiatry. 2012; 169(5): 445-446. Go to original source... Go to PubMed...
  55. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. American journal of Psychiatry 1999; 156(10): 1563-1569. Go to original source... Go to PubMed...
  56. Bartak A, Andrea H, Spreeuwenberg MD, Ziegler UM, Dekker J, Rossum BV, Hamers EF, Scholte W, Aerts J, Busschbach JJ, Verheul R. Effectiveness of outpatient, day hospital, and inpatient psychotherapeutic treatment for patients with cluster B personality disorders. Psychotherapy and Psychosomatics 2011; 80(1): 28-38. Go to original source... Go to PubMed...
  57. Paris J. Pharmacological treatments for personality disorders. International Review of Psychiatry 2011; 23(3): 303-309. Go to original source... Go to PubMed...
  58. Bateman A, Fonagy P. 8-year follow‑up of patients treated for borderline personality disorder: mentalization‑based treatment versus treatment as usual. American Journal of Psychiatry 2008; 165(5): 631-638. Go to original source... Go to PubMed...
  59. Brazier J, Tumur I, Holmes M, Ferriter M, Parry G, Dent‑Brown K, Paisley S. Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation. Health Technology Assessment 2006; 10(35). Go to original source... Go to PubMed...
  60. Davidson K, Norrie J, Tyrer P, Gumley A, Tata P, Murray H, Palmer S. The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. Journal of personality disorders 2006; 20(5): 450-465. Go to original source... Go to PubMed...
  61. Farrell JM, Shaw IA, Webber MA. A schema‑focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial. Journal of Behavior Therapy and Experimental Psychiatry 2009; 40(2): 317-328. Go to original source... Go to PubMed...
  62. Giesen‑Bloo J, Van Dyck R, Spinhoven P, Van Tilburg W, Dirksen C, Van Asselt T, Kremers I, Nadort M, Arntz A. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema‑focused therapy vs transference‑focused psychotherapy. Archives of general psychiatry 2006; 63(6): 649-658. Go to original source... Go to PubMed...
  63. Clarkin JF, Levy KN, Lenzenweger MF, Kernberg OF. Evaluating three treatments for borderline personality disorder: A multiwave study. American journal of psychiatry 2007; 164(6): 922-928. Go to original source... Go to PubMed...
  64. Lynch TR, Trost WT, Salsman N, Linehan MM. Dialectical behavior therapy for borderline personality disorder. Annu. Rev. Clin. Psychol 2007; 3: 181-205. Go to original source... Go to PubMed...
  65. Dickey B, Ware NC. Therapeutic communities and mental health system reform. Psychiatric rehabilitation journal 2008; 32(2): 105. Go to original source... Go to PubMed...
  66. Kliem S, Kröger C, Kosfelder J. Dialectical behavior therapy for borderline personality disorder: a meta‑analysis using mixed‑effects modeling. Journal of consulting and clinical psychology 2010; 78(6): 936. Go to original source... Go to PubMed...
  67. Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization‑based treatment versus structured clinical management for borderline personality disorder. American journal of Psychiatry 2009; 166(12): 1355-1364. Go to original source... Go to PubMed...
  68. Stoffers JM, Lieb K. Pharmacotherapy for borderline personality disorder-current evidence and recent trends. Current psychiatry reports 2015; 17(1): 534. Go to original source... Go to PubMed...
  69. Starcevic V, Janca A. Pharmacotherapy of borderline personality disorder: replacing confusion with prudent pragmatism. Current opinion in psychiatry 2018; 31(1):69-73. Go to original source... Go to PubMed...
  70. Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. American Journal of Psychiatry 2005; 162(3): 621-624. Go to original source... Go to PubMed...
  71. Mercer D, Douglass AB, Links PS. Meta‑analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. Journal of personality disorders 2009; 23(2): 156-174. Go to original source... Go to PubMed...
  72. Frankenburg FR, Zanarini MC. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double‑blind placebo‑controlled pilot study. The Journal of clinical psychiatry 2002; 63(5): 442-426. Go to original source... Go to PubMed...
  73. Reich DB, Zanarini MC, Bieri KA. A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder. International Clinical Psychopharmacology 2009; 24(5): 270-275. Go to original source... Go to PubMed...
  74. Moen R, Freitag M, Miller M, Lee S, Romine A, Song S, Adityanjee A, Schulz SC. Efficacy of extended‑release divalproex combined with "condensed" dialectical behavior therapy for individuals with borderline personality disorder 2012; 24(4): 255-260.
  75. Bozzatello P, Rocca P, Bellino S. Combination of omega-3 fatty acids and valproic acid in treatment of borderline personality disorder: a follow‑up study. Clinical drug investigation 2018; 38(4): 367-372. Go to original source... Go to PubMed...
  76. Crawford MJ, Sanatinia R, Barrett B, Cunningham G, Dale O, Ganguli P, Lawrence‑Smith G, Leeson V, Lemonsky F, Lykomitrou G, Montgomery AA. The clinical effectiveness and cost‑effectiveness of lamotrigine in borderline personality disorder: a randomized placebo‑controlled trial. American Journal of Psychiatry 2018; 175(8): 756-764. Go to original source... Go to PubMed...
  77. Nickel MK, Muehlbacher M, Nickel C, Kettler C, Gil FP, Bachler E, Buschmann W, Rother N, Fartacek R, Egger C, Anvar J. Aripiprazole in the treatment of patients with borderline personality disorder: a double‑blind, placebo‑controlled study. American Journal of Psychiatry 2006; 163(5): 833-888. Go to original source... Go to PubMed...
  78. Bozzatello P, Rocca P, Uscinska M, Bellino S. Efficacy and tolerability of asenapine compared with olanzapine in borderline personality disorder: an open‑label randomized controlled trial. CNS drugs 2017; 31(9): 809-819. Go to original source... Go to PubMed...
  79. O'Leary J, Purcell A, Hynes C, Huet J, Romanos M, McWilliams S. Clozapine for the management of suicidal behavior in borderline personality disorder complicated by a cancer diagnosis: a case report and review of the literature. Journal of clinical psychopharmacology 2018; 38(6): 642-624. Go to original source... Go to PubMed...
  80. Slotema CW, Blom JD, Niemantsverdriet M, Sommer IE. Auditory verbal hallucinations in borderline personality disorder and the efficacy of antipsychotics: a systematic review. Frontiers in psychiatry 2018; 9: 347. Go to original source... Go to PubMed...
  81. Pascual JC, Martín‑Blanco A, Soler J, Ferrer A, Tiana T, Alvarez E, Pérez V. A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines. International clinical psychopharmacology 2010; 25(6): 349-55. Go to original source... Go to PubMed...
  82. Romanowicz M, Schak KM, Voort JL, Leung JG, Larrabee BR, Palmer BA. Prescribing Practices for Patients With Borderline Personality Disorder During Psychiatric Hospitalizations. Journal of personality disorders 2019; 1-4. Go to original source... Go to PubMed...
  83. Armbrust M, Ehrig C. Skillstraining für Patienten mit Borderline‑Störung. PPmP‑Psychotherapie Psychosomatik. Medizinische Psychologie 2016; 66(07): 283-298. Go to original source... Go to PubMed...
  84. Cavelti M, Corbisiero S, Bitto H, Moerstedt B, Newark P, Faschina S, Chanen A, Moggi F, Stieglitz RD. A comparison of self‑reported emotional regulation skills in adults with attention‑deficit/hyperactivity disorder and borderline personality disorder. Journal of attention disorders 2019; 23(12): 1396-1406. Go to original source... Go to PubMed...
  85. Mitchell R, Roberts R, Bartsch D, Sullivan T. Changes in mindfulness facets in a dialectical behaviour therapy skills training group program for borderline personality disorder. Journal of clinical psychology 2019; 75(6): 958-969. Go to original source... Go to PubMed...
  86. Jacob GA, Hauer A, Köhne S, Assmann N, Schaich A, Schweiger U, Fassbinder E. A Schema Therapy-Based eHealth Program for Patients with Borderline Personality Disorder (priovi): Naturalistic Single‑Arm Observational Study. JMIR mental health 2018; 5(4): e10983. Go to original source... Go to PubMed...
  87. Klein JP, Hauer A, Berger T, Fassbinder E, Schweiger U, Jacob G. Protocol for the REVISIT‑HPO Trial, a Randomized Controlled Trial Testing the Effectiveness of an Internet‑Based Self‑Management Intervention in the Treatment of Borderline Personality Disorder (HPO). Frontiers in psychiatry 2018; 9: 439. Go to original source... Go to PubMed...
  88. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V. Axis I comorbidity of borderline personality disorder. American Journal of Psychiatry 1998; 155(12): 1733-1789. Go to original source... Go to PubMed...
  89. Zanarini MC, Frankenburg FR, Dubo ED, Sickel AE, Trikha A, Levin A, Reynolds V. Axis II comorbidity of borderline personality disorder. Comprehensive psychiatry 1998; 39(5): 296-302. Go to original source... Go to PubMed...
  90. American Psychiatric Association. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Pub; 2001.
  91. American Psychiatric Association. American Psychiatric Association Practice Guidelines for the treatment of psychiatric disorders: compendium 2006. American Psychiatric Pub; 2006.
  92. Slade M, Hayward M. Recovery, psychosis and psychiatry: research is better than rhetoric. Acta psychiatrica Scandinavica. 2007 Aug; 116(2): 81. Go to original source... Go to PubMed...
  93. Turton P, Demetriou A, Boland W, Gillard S, Kavuma M, Mezey G, Mountford V, Turner K, White S, Zadeh E, Wright C. One size fits all: or horses for courses? Recovery‑based care in specialist mental health services. Social psychiatry and psychiatric epidemiology 2011; 46(2): 127-136. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.